TY  - JOUR
AU  - Nagorni-Obradović, Ljudmila
AU  - Ignjatović, Svetlana
AU  - Petrović, Vesna
AU  - Mitić-Milikić, Marija
PY  - 2004
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/564
AB  - In this study we determined magnesium concentration in serum and in 24-hour urine, at the start (To) and at the end of treatment (T1), in 56 patients with acute pulmonary disease (B1) and in 58 patients with chronic obstructive pulmonary disease - COPD (B2). In group B1 there was disbalance of Mg in serum in 14-25% patients at the start of treatment (To) which decreased significantly at the end of treatment (T1) and persisted in 4-7.1% patients (p  lt  0.05). In group B2 distribution of normal, decreased and increased values of Mg in serum was similar in patients in period To and T1 (p > 0.05). In group B1, 9 (16.1%) patients had hypomagnesemia at the start of treatment (To), which was accompanied by increased concentration of Mg in 24-hour urine of only 4 (7.2%) patients. There is a possibility that there was extrarenal elimination of Mg in patients with acute pulmonary disease or there was some kind of transcellular distribution. In group B2 in period To, there was proportional ratio between hypomagnesemia (12-20.7% patients) and increased concentration of Mg in 24-hour urine (20 -34.5% patients). This could be because of renal loss. Simultaneous determination and follow up of magnesium in serum and in 24-hour urine can give us reliable information about homeostasis of this electrolyte in acute and chronic pulmonary diseases.
AB  - U ovom radu određivana je koncentracija magnezijuma u serumu i u 24-urinu, na početku (To) i na kraju hospitalnog lečenja (T1) kod 56 bolesnika sa akutnim plućnim bolestima (B1) i kod 58 sa hroničnim plućnim bolestima (B2). U grupi B1 postojao je disbalans Mg u serumu kod 14-25% bolesnika na početku lečenja (To) koji se značajno smanjio na kraju lečenja (T1) i postojao je kod 4-7,1% bolesnika (p  lt  0,05). U grupi B2 distribucija normalnih, snizenih i povišenih vrednosti Mg u serumu bila je slična u periodu To i T1 (p> 0,05). Hipomagnezemiju u grupi B1 imalo je 9 (16,1%) bolesnika na početku lečenja (To) što je bilo praćeno povećanom koncentracijom Mg u 24-časovnom urinu samo kod 4 (7,2%) bolesnika. Ovo je bilo moguće zbog ekstrarenalnog gubitka elektrolita ili je došlo do transcelularne preraspodele. U grupi B2 u periodu To postojao je proporcionalni odnos hipomagnezemije (12,0-20,7% bolesnika) sa povećanom koncentracijom Mg u 24-časovnom urinu (20,0-34,5% bolesnika). Ovo je bilo moguće zbog renalne eliminacije elektrolita. Istovremeno određivanje i praćenje magnezijuma u serumu i 24-časovnom urinu daje pouzdane informacije o homeostazi ovog elektrolita kod akutnih i hroničnih plućnih bolesti.
PB  - Društvo medicinskih biohemičara Srbije i Crne Gore, Beograd i Univerzitet u Beogradu - Farmaceutski fakultet, Beograd
T2  - Jugoslovenska medicinska biohemija
T1  - Magnesium serum and urine concentration in patients with acute and chronic pulmonary disease
T1  - Koncentracija magnezijuma u serumu i urinu kod bolesnika sa akutnim i hroničnim plućnim bolestima
VL  - 23
IS  - 2
SP  - 155
EP  - 160
DO  - 10.2298/JMH0402155N
ER  - 

@article{
author = "Nagorni-Obradović, Ljudmila and Ignjatović, Svetlana and Petrović, Vesna and Mitić-Milikić, Marija",
year = "2004",
abstract = "In this study we determined magnesium concentration in serum and in 24-hour urine, at the start (To) and at the end of treatment (T1), in 56 patients with acute pulmonary disease (B1) and in 58 patients with chronic obstructive pulmonary disease - COPD (B2). In group B1 there was disbalance of Mg in serum in 14-25% patients at the start of treatment (To) which decreased significantly at the end of treatment (T1) and persisted in 4-7.1% patients (p  lt  0.05). In group B2 distribution of normal, decreased and increased values of Mg in serum was similar in patients in period To and T1 (p > 0.05). In group B1, 9 (16.1%) patients had hypomagnesemia at the start of treatment (To), which was accompanied by increased concentration of Mg in 24-hour urine of only 4 (7.2%) patients. There is a possibility that there was extrarenal elimination of Mg in patients with acute pulmonary disease or there was some kind of transcellular distribution. In group B2 in period To, there was proportional ratio between hypomagnesemia (12-20.7% patients) and increased concentration of Mg in 24-hour urine (20 -34.5% patients). This could be because of renal loss. Simultaneous determination and follow up of magnesium in serum and in 24-hour urine can give us reliable information about homeostasis of this electrolyte in acute and chronic pulmonary diseases., U ovom radu određivana je koncentracija magnezijuma u serumu i u 24-urinu, na početku (To) i na kraju hospitalnog lečenja (T1) kod 56 bolesnika sa akutnim plućnim bolestima (B1) i kod 58 sa hroničnim plućnim bolestima (B2). U grupi B1 postojao je disbalans Mg u serumu kod 14-25% bolesnika na početku lečenja (To) koji se značajno smanjio na kraju lečenja (T1) i postojao je kod 4-7,1% bolesnika (p  lt  0,05). U grupi B2 distribucija normalnih, snizenih i povišenih vrednosti Mg u serumu bila je slična u periodu To i T1 (p> 0,05). Hipomagnezemiju u grupi B1 imalo je 9 (16,1%) bolesnika na početku lečenja (To) što je bilo praćeno povećanom koncentracijom Mg u 24-časovnom urinu samo kod 4 (7,2%) bolesnika. Ovo je bilo moguće zbog ekstrarenalnog gubitka elektrolita ili je došlo do transcelularne preraspodele. U grupi B2 u periodu To postojao je proporcionalni odnos hipomagnezemije (12,0-20,7% bolesnika) sa povećanom koncentracijom Mg u 24-časovnom urinu (20,0-34,5% bolesnika). Ovo je bilo moguće zbog renalne eliminacije elektrolita. Istovremeno određivanje i praćenje magnezijuma u serumu i 24-časovnom urinu daje pouzdane informacije o homeostazi ovog elektrolita kod akutnih i hroničnih plućnih bolesti.",
publisher = "Društvo medicinskih biohemičara Srbije i Crne Gore, Beograd i Univerzitet u Beogradu - Farmaceutski fakultet, Beograd",
journal = "Jugoslovenska medicinska biohemija",
title = "Magnesium serum and urine concentration in patients with acute and chronic pulmonary disease, Koncentracija magnezijuma u serumu i urinu kod bolesnika sa akutnim i hroničnim plućnim bolestima",
volume = "23",
number = "2",
pages = "155-160",
doi = "10.2298/JMH0402155N"
}

Nagorni-Obradović, L., Ignjatović, S., Petrović, V.,& Mitić-Milikić, M.. (2004). Magnesium serum and urine concentration in patients with acute and chronic pulmonary disease. in Jugoslovenska medicinska biohemija
Društvo medicinskih biohemičara Srbije i Crne Gore, Beograd i Univerzitet u Beogradu - Farmaceutski fakultet, Beograd., 23(2), 155-160.
https://doi.org/10.2298/JMH0402155N

Nagorni-Obradović L, Ignjatović S, Petrović V, Mitić-Milikić M. Magnesium serum and urine concentration in patients with acute and chronic pulmonary disease. in Jugoslovenska medicinska biohemija. 2004;23(2):155-160.
doi:10.2298/JMH0402155N .

Nagorni-Obradović, Ljudmila, Ignjatović, Svetlana, Petrović, Vesna, Mitić-Milikić, Marija, "Magnesium serum and urine concentration in patients with acute and chronic pulmonary disease" in Jugoslovenska medicinska biohemija, 23, no. 2 (2004):155-160,
https://doi.org/10.2298/JMH0402155N . .